{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:16:50Z","timestamp":1788812210076,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"crossref","award":["PR-HKCH-6"],"award-info":[{"award-number":["PR-HKCH-6"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mitochondrial Diseases (MDs) refers to a heterogeneous group of inherited metabolic disorders resulting in defective cellular energy production due to abnormal oxidative phosphorylation (OXPHOS) caused by pathogenic mitochondrial DNA or nuclear DNA variants. As mitochondria are pivotal for cell bioenergetics, MDs could potentially affect multisystem, leaving a devastating and life-threatening impact. The treatment of MDs present significant challenges due to the complexity of the disease and the wide heterogeneity of its molecular defects. Thus, the need for innovative and more comprehensive therapeutic approaches is evident.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This longitudinal, open-label study was a pilot trial involving 9 paediatric MD patients, aiming to gain a better understanding on the impact of hydroxytyrosol (HT) on the clinical outcomes of MD patients and to assess the feasibility and logistics of using HT as a dietary supplement for MD patients. Subjects received HT daily as dietary supplements for 12 months. Following this period, patients were then randomly assigned to either discontinue HT or continue receiving HT as their dietary supplements for an additional 6 months. Outcome measures that were assessed included the International Paediatric Mitochondrial Disease Scores, biochemical parameters, and quality of life assessments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the outcome measures assessed, HT supplementation demonstrated the most considerable impact on improving the health-related quality of life according to the PedsQL scoring system and potential effects on a subgroup of MD patients with Mitochondrial encephalopathy, lactic acidosis, and stroke-like episode (MELAS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This study demonstrated that HT supplementation resulted in improvement in health-related quality of life in MD patients, while the subgroup of MELAS patients showed additional potential beneficial effect from HT use. As a pilot trial, this study importantly highlighted HT\u2019s tolerability in MD patients, which would facilitate trials of larger scale to be performed in the future.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights the use of HT as a health supplement and its potential therapeutic effects in paediatric patients diagnosed with MDs, especially in MELAS patients. The results lay the foundation for future large-scale clinical trials. Consequently, further clinical intervention studies and investigations into HT\u2019s potential therapeutic mechanisms at the molecular and intercellular levels are strongly encouraged.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03795-0","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:12:20Z","timestamp":1749201140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Open-label pilot study using hydroxytyrosol as dietary supplements in patients with mitochondrial diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Tsz Sum","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Man Carmen","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yee","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ka Yee","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Moti","family":"Belaramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Na","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Mei Kwun","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miu","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby Chun Hei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Yee","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Ling Elaine","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Chun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vansie","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Yin Dick","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Man","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Fung Godfrey","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0105-1673","authenticated-orcid":false,"given":"Cheuk Wing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3795_CR1","unstructured":"Jeanmonod R, Jeanmonod D. Inborn Errors Of Metabolism [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459183\/"},{"key":"3795_CR2","doi-asserted-by":"crossref","unstructured":"Thompson K, Collier JJ, Glasgow RIC, Robertson FM, Pyle A, Blakely EL et al. Recent advances in Understanding the molecular genetic basis of mitochondrial disease. J Inherit Metab Dis. 2019.","DOI":"10.1002\/jimd.12104"},{"key":"3795_CR3","doi-asserted-by":"crossref","unstructured":"Avula S, Parikh S, Demarest S, Kurz J, Gropman A. Treatment of Mitochondrial Disorders. Current treatment options in neurology [Internet]. 2014 Jun 1 [cited 2020 Oct 26];16(6):292. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4067597\/","DOI":"10.1007\/s11940-014-0292-7"},{"key":"3795_CR4","doi-asserted-by":"crossref","unstructured":"Schuck PF, Ferreira BK, Rodrigues MT, Ferreira GC. Mitochondrial dysfunction in inborn errors of metabolism. Elsevier eBooks. 2021;35\u201355.","DOI":"10.1016\/B978-0-323-85666-9.00020-6"},{"issue":"3","key":"3795_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000446586","volume":"7","author":"DM Niyazov","year":"2016","unstructured":"Niyazov DM, Kahler SG, Frye RE. Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol. 2016;7(3):122\u201337.","journal-title":"Mol Syndromol"},{"key":"3795_CR6","doi-asserted-by":"crossref","unstructured":"Rahman J, Rahman S. Mitochondrial medicine in the omics era. The Lancet [Internet]. 2018 Jun [cited 2019 Sep 13];391(10139):2560\u201374.","DOI":"10.1016\/S0140-6736(18)30727-X"},{"key":"3795_CR7","doi-asserted-by":"publisher","first-page":"104008","DOI":"10.1016\/j.jff.2020.104008","volume":"71","author":"S Nuray Yazihan","year":"2020","unstructured":"Nuray Yazihan S, Akdas Y, Olgar D, Biriken, Turan B, MucahitTaha O. Olive oil attenuates oxidative damage by improving mitochondrial functions in human keratinocytes. J Funct Foods. 2020;71:104008\u20138.","journal-title":"J Funct Foods"},{"issue":"1","key":"3795_CR8","first-page":"162","volume":"35","author":"ED Torres-Sanchez","year":"2018","unstructured":"Torres-Sanchez ED, Pacheco-Moises FP, Macias-Islas MA, Morales-Sanchez EW, Ramirez-Ramirez V, de la Celis AJ, et al. Effect of fish and Olive oil on mitochondrial ATPase activity and membrane fluidity in patients with relapsing-remitting multiple sclerosis treated with interferon beta 1-b. Nutr Hosp. 2018;35(1):162\u20138.","journal-title":"Nutr Hosp"},{"issue":"6","key":"3795_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/rej.2012.1346","volume":"15","author":"V Pitozzi","year":"2012","unstructured":"Pitozzi V, Jacomelli M, Catelan D, Servili M, Taticchi A, Biggeri A, et al. Long-term dietary extra-virgin Olive oil rich in polyphenols reverses age-related dysfunctions in motor coordination and contextual memory in mice: role of oxidative stress. Rejuven Res. 2012;15(6):601\u201312.","journal-title":"Rejuven Res"},{"key":"3795_CR10","doi-asserted-by":"crossref","unstructured":"Angeloni C, Malaguti M, Barbalace MC, Hrelia S. Bioactivity of Olive oil phenols in neuroprotection. Int J Mol Sci. 2017;18(11).","DOI":"10.3390\/ijms18112230"},{"key":"3795_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtemb.2016.03.006","volume":"36","author":"M Ogun","year":"2016","unstructured":"Ogun M, Ozcan A, Karaman M, Merhan O, Ozen H, Kukurt A, et al. Oleuropein ameliorates arsenic induced oxidative stress in mice. J Trace Elem Med Biology: Organ Soc Minerals Trace Elem (GMS). 2016;36:1\u20136.","journal-title":"J Trace Elem Med Biology: Organ Soc Minerals Trace Elem (GMS)"},{"key":"3795_CR12","doi-asserted-by":"crossref","unstructured":"Soni M, Prakash C, Sehwag S, Kumar V. Protective effect of Hydroxytyrosol in arsenic-induced mitochondrial dysfunction in rat brain. J Biochem Mol Toxicol. 2017;31(7).","DOI":"10.1002\/jbt.21906"},{"issue":"7","key":"3795_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jnutbio.2009.03.012","volume":"21","author":"J Hao","year":"2010","unstructured":"Hao J, Shen W, Yu G, Jia H, Li X, Feng Z, et al. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem. 2010;21(7):634\u201344.","journal-title":"J Nutr Biochem"},{"key":"3795_CR14","doi-asserted-by":"crossref","unstructured":"Calabriso N, Gnoni A, Stanca E, Cavallo A, Damiano F, Siculella L et al. Hydroxytyrosol Ameliorates Endothelial Function under Inflammatory Conditions by Preventing Mitochondrial Dysfunction. Oxidative medicine and cellular longevity. 2018;2018:9086947.","DOI":"10.1155\/2018\/9086947"},{"key":"3795_CR15","unstructured":"EFSA Panel on Dietetic Products NaAN. Safety of hydroxytyrosol as a novel food pursuant to Regulation (EC) No 258\/97. 2017 European Food Safety Authority EFSA Journal 2017."},{"issue":"11","key":"3795_CR16","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1017\/S0007114515000884","volume":"113","author":"A Zheng","year":"2015","unstructured":"Zheng A, Li H, Xu J, Cao K, Li H, Pu W, et al. Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of Db\/db mice: role of AMP-activated protein kinase activation. Br J Nutr. 2015;113(11):1667\u201376.","journal-title":"Br J Nutr"},{"issue":"10","key":"3795_CR17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/molecules24102001","volume":"24","author":"A Karkovi\u0107 Markovi\u0107","year":"2019","unstructured":"Karkovi\u0107 Markovi\u0107 A, Tori\u0107 J, Barbari\u0107 M, Jakobu\u0161i\u0107 Brala C, Hydroxytyrosol. Tyrosol and derivatives and their potential effects on human health. Molecules. 2019;24(10):2001.","journal-title":"Molecules"},{"key":"3795_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.redox.2016.12.014","volume":"11","author":"E Lopez-Huertas","year":"2017","unstructured":"Lopez-Huertas E, Fonolla J. Hydroxytyrosol supplementation increases vitamin C levels in vivo. A human volunteer trial. Redox Biol. 2017;11:384\u20139.","journal-title":"Redox Biol"},{"issue":"2","key":"3795_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/ars.2018.7704","volume":"31","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Mosca A, Crudele A, Zaffina S, Denaro M, et al. The antioxidant effects of Hydroxytyrosol and vitamin E on paediatric nonalcoholic fatty liver disease, in a clinical trial: A new treatment?? Antioxid Redox Signal. 2019;31(2):127\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"3795_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10545-016-9948-7","volume":"39","author":"S Koene","year":"2016","unstructured":"Koene S, Hendriks JCM, Dirks I, de Boer L, de Vries MC, Janssen MCH, et al. Int Pediatr Mitochondrial Disease Scale J Inherit Metabolic Disease. 2016;39(5):705\u201312.","journal-title":"Int Pediatr Mitochondrial Disease Scale J Inherit Metabolic Disease"},{"key":"3795_CR21","doi-asserted-by":"crossref","unstructured":"Mancuso M, McFarland R, Klopstock T, Hirano M. International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16\u201318 November 2016, Rome, Italy. Neuromuscular disorders: NMD. 2017;27(12):1126-37.","DOI":"10.1016\/j.nmd.2017.08.006"},{"issue":"1","key":"3795_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13613-019-0563-2","volume":"9","author":"B Jung","year":"2019","unstructured":"Jung B, Martinez M, Claessens Y-E, Darmon M, Klouche K, Lautrette A, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensiv Care. 2019;9(1):92.","journal-title":"Ann Intensiv Care"},{"issue":"9","key":"3795_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17(9):689\u2013701.","journal-title":"Genet Med"},{"issue":"2","key":"3795_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10545-010-9081-y","volume":"34","author":"RJ Rodenburg","year":"2011","unstructured":"Rodenburg RJ. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis. 2011;34(2):283\u201392.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3795_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11136-010-9751-0","volume":"20","author":"X Yang","year":"2011","unstructured":"Yang X, Xiao N, Yan J. The PedsQL in paediatric cerebral palsy: reliability and validity of the Chinese version paediatric quality of life inventory 4.0 generic core scales and 3.0 cerebral palsy module. Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation. 2011;20(2):243\u201352.","journal-title":"Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation"},{"issue":"6","key":"3795_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1017\/S001216220600096X","volume":"48","author":"JW Varni","year":"2006","unstructured":"Varni JW, Burwinkle TM, Berrin SJ, Sherman SA, Artavia K, Malcarne VL, et al. The PedsQL in paediatric cerebral palsy: reliability, validity, and sensitivity of the generic core scales and cerebral palsy module. Dev Med Child Neurol. 2006;48(6):442\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"3795_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mito.2016.11.008","volume":"32","author":"SS Wong","year":"2017","unstructured":"Wong SS, Goraj B, Fung CW, Vister J, de Boer L, Koene S, et al. Radboud centre for mitochondrial medicine paediatric MRI score. Mitochondrion. 2017;32:36\u201341.","journal-title":"Mitochondrion"},{"key":"3795_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.fct.2013.01.030","volume":"55","author":"D Au\u00f1on-Calles","year":"2013","unstructured":"Au\u00f1on-Calles D, Canut L, Visioli F. Toxicological evaluation of pure Hydroxytyrosol. Food Chem Toxicol. 2013;55:498\u2013504.","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"3795_CR29","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1039\/D1FO00210D","volume":"12","author":"YT Zhao","year":"2021","unstructured":"Zhao YT, Zhang L, Yin H, Shen L, Zheng W, Zhang K, et al. Hydroxytyrosol alleviates oxidative stress and neuroinflammation and enhances hippocampal neurotrophic signaling to improve stress-induced depressive behaviors in mice. Food Funct. 2021;12(12):5478\u201387.","journal-title":"Food Funct"},{"issue":"9","key":"3795_CR30","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.3390\/ijms25094799","volume":"25","author":"\u00c1 Naranjo","year":"2024","unstructured":"Naranjo \u00c1, Josefa \u00c1lvarez-Soria M, Aranda-Villalobos P, Mart\u00ednez-Rodr\u00edguez AM, Mart\u00ednez-Lara E, Siles E. Hydroxytyrosol, a promising supplement in the management of human stroke: an exploratory study. Int J Mol Sci. 2024;25(9):4799\u20139.","journal-title":"Int J Mol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03795-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:12:26Z","timestamp":1749201146000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3795"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03795-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Hong Kong Hospital Authority Central Institutional Review Board, application code HKCH-REC-2020-027.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their details was obtained from all subjects and\/or their parents\/guardians involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}